Camras Vision is an ophthalmic medical device company developing a solution for 67 million glaucoma sufferers.
Glaucoma is the second leading cause of blindness after cataracts; however, there is a huge gap in the treatment success between these diseases. Cataract surgery is one of the best procedures performed in medicine. There are no drugs on the market to treat cataracts, because the surgery is so safe and effective.
Camras Vision’s goal is to make glaucoma surgery like cataract surgery with our patented device and surgical approach. Our novel technology will provide the first-ever personalized treatment to prevent blindness for each patient.
Camras Vision is an investment of 21st Century Creation’s investment arm.